Thu.Oct 28, 2021

article thumbnail

What’s in a name? Trademarking COVID-19 solutions

Clarivate

The brand name chosen for a vaccine or drug is more than a commercial matter. That’s why trademark analysts also assess for patient safety. Get the full story. Every vaccine and drug goes to market under a distinct brand name, and the COVID-19 vaccines and treatments are no different. Danielle Waterman, Senior Trademark Quality Specialist, Boston, United States.

article thumbnail

New D.Pharmacy Syllabus 2022

Teachntest

New D.Pharmacy Syllabus 2022 From the academic year 2021-22, the Pharmacy Council of India (PCI) has implemented a new D.Pharmacy Syllabus as per education regulations 2020 (ER 2020) for Diploma in Pharmacy throughout the country. ER 2020 has replaced the previous ER 1991. Many subjects have undergone significant changes in the new syllabus concerning modern.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Clarify Health publishes research on quality of care in the United States in 2021

Clarify Health

Clarify Health is a certified national Qualified Entity (QE) of the Centers for Medicare & Medicaid Services (CMS) , which enables us to receive 100% of Medicare Fee-for-Service claims data through the QE Program (also known as the Medicare Data Sharing for Performance Measurement Program). As a QE, we use these data to deliver precision insights via the Clarify Atlas Platform and to evaluate and publicly report on national quality of care measures each year.

article thumbnail

Demystifying the 5G standard essential patent landscape with manual SEP analysis: Phase 2

Clarivate

In a new report 1 , Clarivate patent analysts Gaurav Sawant, Parijat Oak and Ed White identify core patents to 5G standards. In the report Demystifying the 5G standard essential patent landscape with manual SEP (Phase1) published in March 2021, we presented findings from our extensive review of the granted patent families declared essential to 5G as of June 30, 2020.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Clarify Health publishes research on quality of care in the United States in 2021

Clarify Health

Clarify Health is a certified national Qualified Entity (QE) of the Centers for Medicare & Medicaid Services (CMS), which enables us to receive 100% of Medicare Fee-for-Service claims data through the QE Program (also known as the Medicare Data Sharing for Performance Measurement Program). As a QE, we use these data to deliver precision insights [.].

52
article thumbnail

Pharma buys politicians to ensure high drug prices remain

World of DTC Marketing

SUMMARY: Large-cap pharma companies are trading higher in the morning hours after White House unveiled a framework for a deal on President Biden’s social spending package on Thursday leaving out a key provision that allowed Medicare to negotiate lower prescription drug prices. In 2019, Medicare Part D covered more than 3,500 prescription drug products, with total spending of $183 billion, not accounting for rebates.

Pharma 263